Robust EM continual reassessment method in oncology dose finding

Journal of the American Statistical Association

Volumn 106, Issue 495, 2011, Pages 818-831

  Yuan, Ying ^a   Yin, Guosheng ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adaptive design; Expectation maximization algorithm; Late onset toxicity; Maximum tolerated dose; Missing data; Model averaging; Model selection

Indexed keywords

EID: 80054707561     PISSN: 01621459     EISSN: None     Source Type: Journal    
DOI: 10.1198/jasa.2011.ap09476     Document Type: Article

References (30)

1. Akaike, H. (1973), "Information Theory and an Extension of the Maximum Likelihood Principle, " in Second International Symposium on Information Theory, eds. B. N. Petrov and F. Csaki, Budapest: Akademiai Kiado, pp. 267-281. [821]
2. Berkson, J., and Gage, R. P. (1952), "Survival Curve for Cancer Patients Following Treatment, " Journal of the American Statistical Association, 47, 501-515. [821]
3. Braun, T. M. (2002), "The Bivariate Continual Reassessment Method: Extending the CRM to Phase I Trials of Two Competing Outcomes, " Controlled Clinical Trials, 23, 240-256. [818]
4. Buckland, S. T., Burnham, K. P., and Augustin, N. H. (1997), "Model Selection: An Integral Part of Inference, " Biometrics, 53, 603-618. [822]
5. Burnham, D. R., and Anderson, K. P. (2002), Model Selection and Multimodel Inference, New York: Springer. [821]
6. Chevret, S. (2006), Statistical Methods for Dose-Finding Experiments, England: Wiley. [818]
7. Coia, L. R., Myerson, R., and Tepper, J. E. (1995), "Late Effects of Radiation Therapy on the Gastrointestinal Tract, " International Journal of Radiation Oncology, Biology, Physics, 31, 1213-1236. [818]
8. Cooper, J. S., Fu, K., Marks, J., and Silverman, S. (1995), "Late Effects of Radiation Therapy in the Head and Neck Region, " International Journal of Radiation Oncology, Biology, Physics, 31, 1141-1164. [818]
9. Cheung, Y. K., and Chappell, R. (2000), "Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities, " Biometrics, 56, 1177-1182. [818]
10. Dempster, A. P., Laird, N. M., and Rubin, D. B. (1977), "Maximum Likelihood From Incomplete Data via the EM Algorithm" (with discussion), Journal of the Royal Statistical Society, Ser. B, 39, 1-38. [820]
11. Efron, B. (1979), "Bootstrap Methods: Another Look at the Jackknife, " The Annals of Statistics, 7, 1-26. [822]
12. Goodman, S. N., Zahurak, M. L., and Piantadosi, S. (1995), "Some Practical Improvements in the Continual Reassessment Method for Phase I Studies, " Statistics in Medicine, 14, 1149-1161. [818]
13. Heyd, J. M., and Carlin, B. P. (1999), "Adaptive Design Improvements in the Continual Reassessment Method for Phase I Studies, " Statistics in Medicine, 18, 1307-1321. [818]
14. Hjort, N. L., and Claeskens, G. (2003), "Frequentist Model Average Estimators" (with discussion), Journal of the American Statistical Association, 98, 879-899. [822]
15. Hoeting, J. A., Madigan, D., Raftery, A. E., and Volinsky, C. T. (1999), "Bayesian Model Averaging: A Tutorial, " Statistical Science, 14, 382-401. [822]
16. Ishizuka, N., and Ohashi, Y. (2001), "The Continual Reassessment Method and Its Applications: A Bayesian Methodology for Phase I Cancer Clinical Trials, " Statistics in Medicine, 20, 2661-2681. [818]
17. Jin, Z., Ying, Z., and Wei, L. J. (2001), "A Simple Resampling Method by Perturbing the Minimand, " Biometrika, 88, 381-390. [822]
18. Kaplan, E. L., and Meier, P. (1958), "Non-Parametric Estimation From Incomplete Observations, " Journal of the American Statistical Association, 53, 457-481. [821]
19. Leung, D. H.-Y., and Wang, Y.-G. (2002), "An Extension of the Continual Reassessment Method Using Decision Theory, " Statistics in Medicine, 21, 51-63. [818]
20. Little, R. J. A., and Rubin, D. B. (2002), Statistical Analysis With Missing Data (2nd ed.), New York: Wiley. [820]
21. Louis, T. A. (1982), "Finding the Observed Information When Using the EM Algorithm, " Journal of the Royal Statistical Society, Ser. B, 44, 226-233. [821]
22. Møller, S. (1995), "An Extension of the Continual Reassessment Methods Using a Preliminary Up-and-Down Design in a Dose Finding Study in Cancer Patients, in Order to Investigate a Greater Range of Doses, " Statistics in Medicine, 14, 911-922. [818]
23. O'Quigley, J., and Paoletti, X. (2003), "Continual Reassessment Method for Ordered Groups, " Biometrics, 59, 430-440. [818]
24. O'Quigley, J., and Shen, L. Z. (1996), "Continual Reassessment Method: A Likelihood Approach, " Biometrics, 52, 673-684. [818,819,823]
25. O'Quigley, J., Pepe, M., and Fisher, L. (1990), "Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer, " Biometrics, 46, 33-48. [818,819]
26. Piantadosi, S., Fisher, J., and Grossman, S. (1998), "Practical Implementation of a Modified Continual Reassessment Method for Dose Finding Trials, " Cancer Chemotherapy and Pharmacology, 41, 429-436. [818]
27. Raftery, A. E., Madigan, D., and Hoeting, J. A. (1997), "Bayesian Model Averaging for Linear Regression Models, " Journal of the American Statistical Association, 92, 179-191. [821,822]
28. Schwarz, G. (1978), "Estimating the Dimension of a Model, " The Annals of Statistics, 6, 461-464. [822]
29. Shen, L., and O'Quigley, J. (1996), "Consistency of Continual Reassessment Method Under Model Misspecification, " Biometrika, 83, 395-405. [818]
30. Yin, G., and Yuan, Y. (2009), "Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials, " Journal of the American Statistical Association, 104, 954-968. [821]